For only the second time in its history, the Food and Drug Administration last week struck a physician's name from its approved list of researchers who are entitled to test new, investigational drugs on human subjects. The target of the FDA's action was Dr. Albert M. Kligman, a Philadelphia dermatologist, along with "all investigators associated with" three incorporated laboratories of which he is president and director.
Only last year Dr. Kligman, a full professor in the University of Pennsylvania School of Medicine, published what was then hailed as "the most thorough study...
To continue reading:
or
Log-In
